During the past decade, U.O. di Ematologia - Centro Oncologico Basilicata conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "U.O. di Ematologia - Centro Oncologico Basilicata" #1 collaborator was "ERIC Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "U.O. di Ematologia - Centro Oncologico Basilicata" are "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Myeloid Leukaemia" (2 trials), "Acute Myeloid Leukemia With FLT3/ITD Mutation" (1 trials), "B-cell" (1 trials) and "BCR-ABL Positive" (1 trials). Many other conditions were trialed in "U.O. di Ematologia - Centro Oncologico Basilicata" in a lesser frequency.

Most popular intervention types in "U.O. di Ematologia - Centro Oncologico Basilicata" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Antibiotic and antifungal drugs" (1 trials), "Bendamustine + Rituximab" (1 trials), "Bosutinib" (1 trials), "Cytarabine" (1 trials) and "Cytarabine HD" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.O. di Ematologia - Centro Oncologico Basilicata" are 9 trials for "All" genders.

Currently, there are NaN active trials in "U.O. di Ematologia - Centro Oncologico Basilicata". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in U.O. di Ematologia - Centro Oncologico Basilicata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in U.O. di Ematologia - Centro Oncologico Basilicata, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".